SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.28+0.5%Nov 5 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (1209)1/7/2002 10:50:34 PM
From: scaram(o)uche  Read Replies (2) of 1475
 
Nope.

You bleed those who received the vaccine and fractionate the IgG antibody fraction from pooled plasma. The Eligix products are used to fractionate cell preparations.

I presume that the donors would have their cells returned to them, but they'd be separated from the plasma by simple centrifugation.

BTW..... this would provide very effective protection, and passive IgG has proven to be extremely safe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News